COVID Vaccinations - Lessons Learned | Locked...

A strong marketing strategy depends on the variety and relevance of your content. In this episode, we dive into what a diverse content strategy is, why it matters, and how it can elevate your marketing efforts. We’ll highlight the key benefits of producing varied content, common ...  Show more

Today’s guest shares my mission to empower others to take control of their health and address the root cause. We talk about challenges to testing and addressing the foundations of health, which begins with Minerals & Metals. Jeff Lioon is the Creative Director at The Oligoscan. H ...  Show more

Special guests Lauren B. Angelo, PharmD, MBA from the Rosalind Franklin University of Medicine and Science and Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP from the Virginia Commonwealth University School of Pharmacy join us to talkabout influenza vaccines.Listen in a ...  Show more

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ...  Show more

The Real Story About COVID Vaccines: What We Know, What We Don’t | This episode is brought to you by Bioptimizers, Thrive Market, and Athletic Greens. There’s no way around it, we’re being bombarded by an insane amount of information when it comes to COVID-19, and not all of it m ...  Show more

In Europe, the COVID-19 vaccine rollout has been slow. The U.S. is doing better — vaccinating as many as 3 million people per day this past weekend. Some of those people were vaccinated by Chichi Ilonzo Momah, who runs Springfield Pharmacy in Springfield, Pa. Momah says local ind ...  Show more